I just heard from Mightycydy, one of our excellent board members, cautioning me that Dr Baron's July 4 poster presentation at ESMO in Barcelona may be focused on updating patient data from CYDY's previous CRC trial instead of the 2025 trial. Mighty's take would be consistent with what is about to occur in Munich and Vienna re updating patient data from CYDY's mTNBC clinical trial in 2020-21. If so, that patient data could also be very interesting and useful.
And though it would be even better if Barcelona will be be a report on current CRC patients, I remain very hopeful that, either way, presenting in Munich, Vienna, and Barcelona within the span of about 2 months foreshadows a rewarding focus and imminent relationship with the EMA and Europe.